vs

Side-by-side financial comparison of FONAR CORP (FONR) and John Marshall Bancorp, Inc. (JMSB). Click either name above to swap in a different company.

FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $16.8M, roughly 1.5× John Marshall Bancorp, Inc.). John Marshall Bancorp, Inc. runs the higher net margin — 36.3% vs 8.0%, a 28.3% gap on every dollar of revenue. Over the past eight quarters, John Marshall Bancorp, Inc.'s revenue compounded faster (15.3% CAGR vs -0.3%).

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

John Marshall Bancorp, Inc. is a U.S.-based bank holding company that operates through its wholly owned subsidiary John Marshall Bank. It provides a full suite of commercial and consumer banking products including deposit accounts, commercial loans, residential mortgages, and personal financial services, primarily serving retail customers and small-to-mid-sized businesses across the U.S. Mid-Atlantic region.

FONR vs JMSB — Head-to-Head

Bigger by revenue
FONR
FONR
1.5× larger
FONR
$25.5M
$16.8M
JMSB
Higher net margin
JMSB
JMSB
28.3% more per $
JMSB
36.3%
8.0%
FONR
Faster 2-yr revenue CAGR
JMSB
JMSB
Annualised
JMSB
15.3%
-0.3%
FONR

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
FONR
FONR
JMSB
JMSB
Revenue
$25.5M
$16.8M
Net Profit
$2.1M
$6.1M
Gross Margin
Operating Margin
13.5%
Net Margin
8.0%
36.3%
Revenue YoY
2.4%
Net Profit YoY
4.7%
26.8%
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FONR
FONR
JMSB
JMSB
Q1 26
$16.8M
Q4 25
$25.5M
$16.4M
Q3 25
$26.0M
$16.3M
Q2 25
$27.3M
$15.4M
Q1 25
$27.2M
$14.6M
Q4 24
$24.9M
$14.3M
Q3 24
$25.0M
$13.8M
Q2 24
$25.9M
$12.6M
Net Profit
FONR
FONR
JMSB
JMSB
Q1 26
$6.1M
Q4 25
$2.1M
$5.9M
Q3 25
$2.3M
$5.4M
Q2 25
$729.3K
$5.1M
Q1 25
$2.5M
$4.8M
Q4 24
$2.0M
$4.8M
Q3 24
$3.1M
$4.2M
Q2 24
$830.4K
$3.9M
Operating Margin
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
13.5%
47.4%
Q3 25
14.1%
42.2%
Q2 25
5.3%
42.7%
Q1 25
15.2%
42.4%
Q4 24
11.9%
42.5%
Q3 24
21.0%
38.8%
Q2 24
7.4%
39.7%
Net Margin
FONR
FONR
JMSB
JMSB
Q1 26
36.3%
Q4 25
8.0%
36.2%
Q3 25
8.7%
33.2%
Q2 25
2.7%
33.1%
Q1 25
9.2%
32.9%
Q4 24
7.9%
33.3%
Q3 24
12.6%
30.7%
Q2 24
3.2%
30.9%
EPS (diluted)
FONR
FONR
JMSB
JMSB
Q1 26
$0.43
Q4 25
$0.41
Q3 25
$0.38
Q2 25
$0.36
Q1 25
$0.34
Q4 24
$0.33
Q3 24
$0.30
Q2 24
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FONR
FONR
JMSB
JMSB
Cash + ST InvestmentsLiquidity on hand
$121.0K
$150.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$176.9M
$268.1M
Total Assets
$217.2M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FONR
FONR
JMSB
JMSB
Q1 26
$150.2M
Q4 25
$121.0K
$130.0M
Q3 25
$122.0K
$163.6M
Q2 25
$56.5M
$116.9M
Q1 25
$123.0K
$169.1M
Q4 24
$121.0K
$122.5M
Q3 24
$136.0K
$177.2M
Q2 24
$56.5M
$182.6M
Total Debt
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
$80.9M
Q3 25
$80.9M
Q2 25
$80.8M
Q1 25
$80.8M
Q4 24
$80.8M
Q3 24
$80.8M
Q2 24
$66.9K
$24.7M
Stockholders' Equity
FONR
FONR
JMSB
JMSB
Q1 26
$268.1M
Q4 25
$176.9M
$265.6M
Q3 25
$174.9M
$259.7M
Q2 25
$172.6M
$253.7M
Q1 25
$171.9M
$253.0M
Q4 24
$169.8M
$246.6M
Q3 24
$168.7M
$243.1M
Q2 24
$166.0M
$235.3M
Total Assets
FONR
FONR
JMSB
JMSB
Q1 26
$2.4B
Q4 25
$217.2M
$2.3B
Q3 25
$218.4M
$2.3B
Q2 25
$216.9M
$2.3B
Q1 25
$214.9M
$2.3B
Q4 24
$208.0M
$2.2B
Q3 24
$212.3M
$2.3B
Q2 24
$214.2M
$2.3B
Debt / Equity
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
0.30×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.32×
Q4 24
0.33×
Q3 24
0.33×
Q2 24
0.00×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FONR
FONR
JMSB
JMSB
Operating Cash FlowLast quarter
$171.0K
Free Cash FlowOCF − Capex
$-227.0K
FCF MarginFCF / Revenue
-0.9%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
$171.0K
$22.6M
Q3 25
$1.7M
$1.2M
Q2 25
$4.2M
$7.5M
Q1 25
$3.1M
$7.0M
Q4 24
$2.2M
$17.3M
Q3 24
$1.7M
$1.4M
Q2 24
$4.6M
$10.2M
Free Cash Flow
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
$-227.0K
$22.0M
Q3 25
$-177.0K
$1.2M
Q2 25
$3.6M
$7.4M
Q1 25
$2.6M
$6.6M
Q4 24
$1.5M
$16.8M
Q3 24
$-148.0K
$1.3M
Q2 24
$4.2M
$10.1M
FCF Margin
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
-0.9%
134.7%
Q3 25
-0.7%
7.3%
Q2 25
13.1%
47.8%
Q1 25
9.4%
45.3%
Q4 24
6.0%
116.9%
Q3 24
-0.6%
9.5%
Q2 24
16.1%
80.1%
Capex Intensity
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
1.6%
3.4%
Q3 25
7.2%
0.2%
Q2 25
2.4%
1.0%
Q1 25
2.2%
2.3%
Q4 24
3.0%
3.4%
Q3 24
7.2%
0.8%
Q2 24
1.6%
0.4%
Cash Conversion
FONR
FONR
JMSB
JMSB
Q1 26
Q4 25
0.08×
3.82×
Q3 25
0.75×
0.23×
Q2 25
5.79×
1.48×
Q1 25
1.26×
1.45×
Q4 24
1.14×
3.61×
Q3 24
0.53×
0.33×
Q2 24
5.54×
2.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

JMSB
JMSB

Net Interest Income$16.5M98%
Noninterest Income$284.0K2%

Related Comparisons